What's new?

Sofinnova Partners Announces Sale of Corvidia Therapeutics to Novo Nordisk

Novo Nordisk acquires Corvidia for $2.1B with an upfront payment of $725M in cash   Sofinnova Partners co-founded Corvidia as its sole seed financial investor in 2015 with serial entrepreneur Michael Davidson   PARIS, France – June 11, 2020 - Sofinnova Partners, a leading European life sciences venture capital firm...

Mainstay Medical Announces US$108 Million Equity Financing Transaction

Funding to support U.S. commercial launch and global expansion   February 16, 2021 08:00 AM Eastern Standard Time - DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings plc (“Mainstay” or the “Company”) today announced the closing of an equity financing in which it raised gross proceeds of US$108 million. Mainstay in...

EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden

EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and power of nature with the efficiencies of state-of-the-art chemical processing techniques   February 11, 2021 01:00 AM Eastern Standard Time STOCKHOLM--(BUSINESS WIRE)--EnginZym...

Enthera Pharmaceuticals Extends Series A Financing, Raising a Total Of €35m

The Roche Venture Fund joins international investor syndicate, including co-lead investors Sofinnova Partners and AbbVie Ventures Funds to be used to advance restorative therapy for type 1 diabetes and inflammatory bowel disease   Largest international VC-backed Series A financing round for a biotech in Italy to da...

Biotalys Submits First Protein-Based Biocontrol Registration Package to the EPA

GHENT, Belgium and RESEARCH TRIANGLE PARK, N.C., Jan. 21, 2021 (GLOBE NEWSWIRE) --   Today, Biotalys NV, a transformative food and crop protection company, announces that it has submitted its first protein-based biocontrol, Evoca™, to the Environmental Protection Agency (EPA) in the United States for approval. Pend...

Moon Surgical (formerly MastOR) announces appointment of experienced core team to accelerate development

Paris, France & San Francisco, California, USA, January 13th, 2021 -   Moon Surgical, formerly MastOR, is delighted to announce the addition of three seasoned medtech executives to the leadership team: Jeffery Alvarez as Chief Operating Officer, David Noonan as Chief Technology Officer, and Nicolas Linard as Head o...

CorWave Raises €35 Million in Series C Funding for Its Breakthrough Heart Pump; EIC Fund Joins as New Investor

Clichy, France, January 6th, 2021 –   CorWave raises 35 million euros to fund the next stages of its development, with the ambition to become a world-class medtech company serving heart failure patients.   The capital increase is subscribed by returning investors joined by the EIC Fund, the European Commission's ve...

Peijia Medical and HighLife Enter Into License and Technology Transfer Agreement for Transeptal Mitral Valve Replacement in Greater China

Collaboration Strengthens Peijia's Position for Competing in a Largely Untapped Market and Supports Global Expansion of HighLife's Technology   SUZHOU, China and PARIS, Dec. 20, 2020/PRNewswire/ --   Peijia Medical Ltd (HK Stock Code: 09996) and HighLife SAS, a Paris-based medical device company, focused on the dev...

CorVent Medical announces strategic partnership with Siemens Healthineers for distribution of the RESPOND-19™ Ventilator

The U.S. agreement expands Siemens Healthineers respiratory care portfolio to include critical care ventilators   NEW YORK, Dec. 15, 2020 /PRNewswire/ --    CorVent Medical, a Coridea portfolio company focused on developing smart, reusable, lifesaving ventilators for critical care, announced today an agreement with...

Sonova invests €5 million in Sensorion as the companies plan a collaboration in hearing loss

Sonova invests at €1.70 per share, to hold circa 3.7% stake in Sensorion Companies signed a letter of intent relating to a collaboration to develop new solutions for hearing loss   December 15, 2020 01:00 AM Eastern Standard Time MONTPELLIER, France--(BUSINESS WIRE)--   Regulatory News:   Sensorion (Paris:ALSEN) (F...

GenSight Biologics Announces Publication of Results from LUMEVOQ® REVERSE Pivotal Phase III Trial and Non-Human Primate Study in Science Translational Medicine

First publication based on Phase III data to document sustained and clinically meaningful bilateral improvement in visual acuity from unilateral injection of a gene therapy Non-human primate study clarifies mechanism behind contralateral effect   Paris, France, December 10, 2020, 7:30 am CET –   GenSight Biologics ...

1 2 3 ... 183